Skip to main content

Table 4 Changes of medication from baseline to 24 months follow-up among patients with improvements of the HbA1c level of more than 0.2%, by group

From: Patient-centered communication and shared decision making to reduce HbA1c levels of patients with poorly controlled type 2 diabetes mellitus - results of the cluster-randomized controlled DEBATE trial

 

Group

Total

Intervention

Control

Diabetes Medication

Diabetes Medication

Diabetes Medication

Less

No change

More

Less

No change

More

Less

No change

More

No improvement

Numbers

38

156

71

40

116

68

78

272

139

Percentages

14%

59%

27%

18%

52%

30%

16%

56%

28%

Improvement

Numbers

14

35

24

8

47

26

22

82

50

Percentages

19%

48%

33%

10%

58%

32%

14%

53%

32%